Can a simple blood test predict rebleeding in gut vessel disease?
NCT ID NCT07183995
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will check 55 adults with gastrointestinal angiodysplasia—abnormal blood vessels in the gut that can cause bleeding—for related blood disorders, especially problems with von Willebrand factor, a protein that helps blood clot. Researchers want to see if low levels of this protein can predict who will bleed again or die in the hospital. Participants will undergo standard tests like endoscopy, colonoscopy, and blood work. The study does not test any new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better predict which patients with GI angiodysplasia are at risk of rebleeding, potentially guiding more personalized monitoring or treatment.
What could go wrong
This is an observational study with only 55 participants, so results may not apply to everyone. It aims to find associations, not test a treatment, so it won't directly change care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GI BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••